Kestra Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,754
| Closed | -$686K | – | 2656 |
|
|
2024
Q3 | $686K | Buy |
9,754
+620
| +7% | +$43.6K | ﹤0.01% | 1555 |
|
|
2024
Q2 | $752K | Sell |
9,134
-9,251
| -50% | -$762K | ﹤0.01% | 1496 |
|
|
2024
Q1 | $1.61M | Buy |
18,385
+3,095
| +20% | +$270K | 0.01% | 984 |
|
|
2023
Q4 | $1.47M | Buy |
15,290
+1,456
| +11% | +$140K | 0.01% | 949 |
|
|
2023
Q3 | $1.22M | Buy |
13,834
+2,817
| +26% | +$249K | 0.01% | 902 |
|
|
2023
Q2 | $955K | Buy |
11,017
+712
| +7% | +$61.7K | 0.01% | 1002 |
|
|
2023
Q1 | $1M | Buy |
10,305
+558
| +6% | +$54.3K | 0.01% | 947 |
|
|
2022
Q4 | $1.01M | Buy |
9,747
+3,001
| +44% | +$311K | 0.01% | 1053 |
|
|
2022
Q3 | $572K | Buy |
6,746
+449
| +7% | +$38.1K | 0.01% | 1243 |
|
|
2022
Q2 | $522K | Sell |
6,297
-1,714
| -21% | -$142K | 0.01% | 1308 |
|
|
2022
Q1 | $618K | Buy |
8,011
+4,277
| +115% | +$330K | 0.01% | 1172 |
|
|
2021
Q4 | $330K | Sell |
3,734
-237
| -6% | -$20.9K | ﹤0.01% | 1547 |
|
|
2021
Q3 | $307K | Buy |
3,971
+300
| +8% | +$23.2K | ﹤0.01% | 1652 |
|
|
2021
Q2 | $306K | Buy |
3,671
+408
| +13% | +$34K | ﹤0.01% | 1552 |
|
|
2021
Q1 | $246K | Buy |
+3,263
| New | +$246K | ﹤0.01% | 1590 |
|